WASHINGTON, DC – House Energy and Commerce Committee Chairman Fred Upton (R-MI) today welcomed long-sought progress on H.R. 2094, the School Access to Emergency Epinephrine Act. This bipartisan legislation is designed to help children suffering from allergies by encouraging and clarifying protections for schools to keep emergency supplies of epinephrine available in case a child suffers a life-threatening allergic reaction. The bill amends the Children’s Asthma Treatment Grants Program and other asthma programs administered by the Department of Health and Human Services (HHS) and allows a preference in awarding asthma grants to states with emergency epinephrine programs that meet specific requirements. The measure, which now heads to the president’s desk for signature, was approved by the Energy and Commerce Committee and the full House in July of this year. H.R. 2094 is supported by the American Academy of Emergency Medicine.
“Today we are one step closer to supporting our nation’s schools in their efforts to be prepared to treat students with severe allergic reactions,” said Energy and Commerce Committee Chairman Fred Upton. “This legislation will have a profound impact on students across Michigan and the country as they can rest assured that when called upon, our schools will have the ability to deliver immediate treatment that will save lives.”
“This is an important, bipartisan achievement that will help deliver peace of mind to parents, teachers, and students,” said Health Subcommittee Chairman Joe Pitts (R-PA). “Providing schools with the guidance they need to care for students is of the utmost importance. I look forward to seeing this legislation become law with the president’s signature.”
Chairman Fred Upton signs H.R. 2094 as the designated Speaker Pro Tempore, bringing the legislation one step closer to enactment. H.R. 2094 is bipartisan legislation sponsored by Reps. Phil Roe (R-TN) and Steny Hoyer (D-MD).